Serac Life Sciences

Dr Tatjana Gibbons, an investigator on the study from the Nuffield Dept of Women's & Reproductive Health, University of Oxford gave a Top Rated Oral Presentation on our DETECT endometriosis imaging study at the European Association of Nuclear Medicine (EANM) annual congress earlier this week.   The presentation at EANM added to the initial findings as previously presented at two women’s health congresses earlier in the year, indicating that 99mTc-maraciclatide has potential as a non-invasive test for early-stage endometriosis. The presentation at EANM gave the Oxford University team the opportunity to discuss the potential of our molecular imaging agent with this important nuclear medicine audience. #endometriosis #womenshealth #molecularimaging #diagnosticimaging #medicalimaging #precisionmedicine #nuclearmedicine #EANM24 Hermes Medical Solutions Spectrum Dynamics Medical

The first clinical results using Seracam® for small organ imaging have been presented at European Association of Nuclear Medicine (EANM) Congress 2024 in Hamburg, Germany. The study involves a comparison of the diagnostic accuracy and resolution of radiopharmaceutical uptake between Seracam® and standard gamma cameras in a range of different procedures.   The e-poster submitted by Serac Imaging Systems’ clinical partners from the University of Malaya Medical Centre and Taylor's University, Malaysia includes case studies and images from a range of patients including parathyroid, lymphoscintigraphy and bone scan investigations.   The findings demonstrate that Seracam® is highly suited to small field-of-view imaging applications such as thyroid and parathyroid using Tc-99m and I-131; sentinel node localisation studies and bone spot views, among others.   For full details, please see the press release here: https://lnkd.in/gEgTgeuc   Intan Noorliyana Md Musidek, Aik Hao Ng, Chai Hong Yeong, Alan Perkins University of Malaya, Taylor's University, Hermes Medical Solutions #EANM24 #nuclearmedicine #smallorganimaging #medicalimaging #hybridimaging #thyroidimaging #lymphoscintigraphy  

A great start to the EANM Congress for the Serac Healthcare team!

Our CEO, Mark Rosser, will be heading off to Hamburg later this week to attend the annual European Association of Nuclear Medicine (EANM) congress taking place from 19-23 October. He will be available to discuss the latest developments with Seracam, including the first presentation of results from a small organ imaging study running in Malaysia, which will be presented in e-poster number EP-0715 throughout the conference. The abstract “SFoV Imaging Using a Hybrid Optical-Gamma Camera (HGC): Specifications and First Clinical Result” is accessible in the EANM ’24 Abstract book accessible until 7th November: https://lnkd.in/eKGB35vr And on our website here: https://lnkd.in/ewMry5yp Intan Noorliyana Md Musidek, Aik Hao Ng, Chai Hong Yeong, Alan Perkins University of Malaya, Taylor's University, Hermes Medical Solutions #EANM24 #nuclearmedicine #smallorganimaging #medicalimaging #hybridimaging #thyroidimaging

Fantastic to see these encouraging first results from Seracam® in image guided surgery!

Further research on the development of AI tools to enhance the potential of ⁹⁹ᵐTc-maraciclatide as a new imaging marker has been presented today by Robert Cobb from the School of Biomedical Engineering & Imaging Sciences, King’s College London (KCL). A poster at the annual conference of the Medical Image Computing and Computer Assisted Intervention Society (MICCAI Society) illustrates the latest methodology used in the ongoing research collaboration led by Professor Andrew Reader and Professor Gary Cook at KCL to develop AI tools to help clinicians read and interpret scans using ⁹⁹ᵐTc-maraciclatide. For more details, please see the press release here: https://lnkd.in/eQMJyu4s And high res poster here: https://lnkd.in/evi8UQux ⁹⁹ᵐTc-maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities. #molecularimaging #medicalimaging #AI #machinelearning #rheumatoidarthritis #endometriosis #nuclearmedicine #precisionmedicine #MICCAI2024 #inflammatoryarthritis

We are preparing for the annual European Association of Nuclear Medicine (EANM) congress taking place in Hamburg from 19-23 October.  David Hail Paul Cload and Jon Barnett will be attending and available to discuss the ongoing DETECT study which is evaluating maraciclatide as a molecular imaging marker for endometriosis.   Dr Tatjana Gibbons, one of the key investigators on the study from the Nuffield Dept of Women's & Reproductive Health, University of Oxford, will be presenting findings from the study in a Top Rated Oral Presentation session: Session Date:                          Sunday, October 20, 2024 Session Time:                          9:45:00 AM - 11:15:00 AM Presentation Number:          OP-116 Session Number:                     307 Session Title:                            TROP Session: Paediatrics Committee: Paediatric Nephrourology & Others Session Hall:                             Hall Y10-Y12   The abstract “Visualisation of Superficial Peritoneal Endometriosis with 99mTc-maraciclatide” has now been published in the EANM ’24 Abstract book here (until 7 November): https://lnkd.in/ez-7hM-8 and our website here: https://lnkd.in/ezkX2rm7   #endometriosis #womenshealth #molecularimaging #diagnosticimaging #medicalimaging #precisionmedicine #nuclearmedicine #EANM2024 Hermes Medical Solutions Spectrum Dynamics Medical

Serac Healthcare's CEO, David Hail, is attending this event in London tomorrow. Please do get in touch if you'd like to meet with him there.

Our CEO Mark Rosser will be joining this conference organised by the International Atomic Energy Agency (IAEA), taking place this week in Vienna. Intan Noorliyana Md Musidek from the Faculty of Medicine at the University of Malaya will be giving an oral presentation on the first results from a clinical trial running in Malaysia using our hybrid gamma-optical camera, Seracam®, in image guided surgery. The trial is comparing the detection of sentinel lymph nodes in biopsy procedures in patients with breast cancer with standard gamma probe detection. Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. #nuclearmedicine #hybridimaging #pointofcareimaging #smalloranimaging #breastcancer #sentinellymphnodebiopsy #IPET2024

Great to see Serac Healthcare involved in this network!